These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 7549902)
41. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases. Raspadori D; Lauria F; Ventura MA; Rondelli D; Visani G; de Vivo A; Tura S Leuk Res; 1997 Jul; 21(7):603-7. PubMed ID: 9301680 [TBL] [Abstract][Full Text] [Related]
42. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies. Hast R; Dowding C; Robak T; Goldman JM Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449 [TBL] [Abstract][Full Text] [Related]
43. [A study on the diagnostic criteria for adult acute myeloid leukemia with morphology, immunology and cytogenetics]. Liu Z; Zhang X; Xue Y Zhonghua Nei Ke Za Zhi; 1996 Jun; 35(6):392-6. PubMed ID: 9387628 [TBL] [Abstract][Full Text] [Related]
45. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Drexler HG; Thiel E; Ludwig WD Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419 [TBL] [Abstract][Full Text] [Related]
46. HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia. Guo QY; Chen BG; Ruan YY; Lin A; Yan WH Leuk Res; 2011 Oct; 35(10):1350-4. PubMed ID: 21696824 [TBL] [Abstract][Full Text] [Related]
47. Acute myelogenous leukemia with T-cell features. Ribrag V; Bayle C; Brault P; Bodis S; Magherini E; Hayat M Bull Cancer; 1992; 79(12):1165-71. PubMed ID: 1304836 [TBL] [Abstract][Full Text] [Related]
48. [The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia]. Chen GB; Tang MH; Yang TY Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):405-8. PubMed ID: 7903627 [TBL] [Abstract][Full Text] [Related]
49. Myeloid antigen expression in adult acute lymphoblastic leukemia: clinicohematological correlations and prognostic relevance. Ferrara F; De Rosa C; Fasanaro A; Mele G; Finizio O; Schiavone EM; Spada OA; Rametta V; Del Vecchio L Hematol Pathol; 1990; 4(2):93-8. PubMed ID: 2373674 [TBL] [Abstract][Full Text] [Related]
50. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes. Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966 [TBL] [Abstract][Full Text] [Related]
51. [Immunophenotypic and cytogenetic features of acute myelomonocytic leukemia]. Zhou HF; Li JY; Wu YJ; Yang H; Qiu HR; Li L Ai Zheng; 2006 Oct; 25(10):1252-5. PubMed ID: 17059770 [TBL] [Abstract][Full Text] [Related]
52. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia. Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689 [TBL] [Abstract][Full Text] [Related]
53. [Immunophenotype of acute leukemia and its clinical significance]. Zhu H; Niu T; Meng W; Xu C; Lei S Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):118-20. PubMed ID: 12599447 [TBL] [Abstract][Full Text] [Related]
54. Clinical significance of standard CD assessment in acute leukemia. Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517 [TBL] [Abstract][Full Text] [Related]
55. CD7 expression in acute myeloid leukemia. Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657 [TBL] [Abstract][Full Text] [Related]
56. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524 [TBL] [Abstract][Full Text] [Related]
57. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies. Robak T; Korycka A Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133 [TBL] [Abstract][Full Text] [Related]
58. [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL]. Liu B; Li R; Wu HJ; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):421-4. PubMed ID: 17493361 [TBL] [Abstract][Full Text] [Related]
59. Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers. Lo Coco F; Pasqualetti D; Lopez M; Panzini E; Gentile A; Latagliata R; Monarca B; De Rossi G Blut; 1989 May; 58(5):235-40. PubMed ID: 2720173 [TBL] [Abstract][Full Text] [Related]
60. [Immunophenotypes, cytogenetics and clinical features of 192 patients with acute myeloid leukemia]. Tong HX; Wang HH; Zhang JH; Liu ZG; Zheng YC; Wang YX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1174-8. PubMed ID: 19840445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]